Trial · NCT00480025
Adverse events820
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 820
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Arthralgia | Musculoskeletal and connective tissue disorders | GSK1572932 Group | 105 | 1,515 | 161 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Placebo Group | 31 | 757 | 35 |
| other | Asthenia | General disorders | GSK1572932 Group | 92 | 1,515 | 199 |
| other | Asthenia | General disorders | Placebo Group | 26 | 757 | 55 |
| other | Chills | General disorders | GSK1572932 Group | 118 | 1,515 | 249 |
| other | Chills | General disorders | Placebo Group | 7 | 757 | 16 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | GSK1572932 Group | 131 | 1,515 | 155 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Placebo Group | 71 | 757 | 80 |
| other | Decreased appetite | Metabolism and nutrition disorders | GSK1572932 Group | 79 | 1,515 | 112 |
| other | Decreased appetite | Metabolism and nutrition disorders | Placebo Group | 28 | 757 | 30 |
| other | Diarrhoea | Gastrointestinal disorders | GSK1572932 Group | 76 | 1,515 | 110 |
| other | Diarrhoea | Gastrointestinal disorders | Placebo Group | 31 | 757 | 42 |
| other | Dyspnoea | Respiratory, thoracic and mediastinal disorders | GSK1572932 Group | 83 | 1,515 | 91 |
| other | Dyspnoea | Respiratory, thoracic and mediastinal disorders | Placebo Group | 47 | 757 | 52 |
| other | Erythema | Skin and subcutaneous tissue disorders | GSK1572932 Group | 120 | 1,515 | 258 |
| other | Erythema | Skin and subcutaneous tissue disorders | Placebo Group | 6 | 757 | 6 |
| other | Fatigue | General disorders | GSK1572932 Group | 243 | 1,515 | 579 |
| other | Fatigue | General disorders | Placebo Group | 50 | 757 | 85 |
| other | Headache | Nervous system disorders | GSK1572932 Group | 129 | 1,515 | 241 |
| other | Headache | Nervous system disorders | Placebo Group | 40 | 757 | 50 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00480025/events